Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response
Sean P. Korpela, Trista K. Hinz, Ayman Oweida, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

Multiplex Tissue Imaging: Spatial Revelations in the Tumor Microenvironment
Stephanie van Dam, Matthijs J.D. Baars, Yvonne Vercoulen
Cancers (2022) Vol. 14, Iss. 13, pp. 3170-3170
Open Access | Times Cited: 48
Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response
Emily K. Kleczko, Anh T. Le, Trista K. Hinz, et al.
Cancer Letters (2023) Vol. 556, pp. 216062-216062
Open Access | Times Cited: 17
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients
Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuarán, et al.
European Journal of Cancer (2022) Vol. 174, pp. 287-298
Open Access | Times Cited: 24
EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
James Kang, Albert I. Ko, Sang Hoon Kil, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188827-188827
Closed Access | Times Cited: 23
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity
Emily K. Kleczko, Trista K. Hinz, Teresa T. Nguyen, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 14
The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations
Michihisa Kono, Shin Saito, Ann Marie Egloff, et al.
Oral Oncology (2022) Vol. 132, pp. 106012-106012
Open Access | Times Cited: 21
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
Ritu Chaudhary, Robbert J.C. Slebos, Leenil C. Noel, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 5, pp. 896-907
Open Access | Times Cited: 8
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research
Alina Bollhagen, Bernd Bodenmiller
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2071-2088
Open Access | Times Cited: 3
Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models
Daniel J Sisler, Trista K. Hinz, Anh‐Tuan Le, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Plasma cell-free circRNAs panel act as fingerprint predicts the occurrence of laryngeal squamous cell carcinoma
Jiahui Han, Qiuhong Lin, Chunguang Dong
Aging (2021) Vol. 13, Iss. 13, pp. 17328-17336
Open Access | Times Cited: 12
High Expression of Interferon Pathway Genes CXCL10 and STAT2 Is Associated with Activated T-Cell Signature and Better Outcome of Oral Cancer Patients
Yun-Cian Huang, Chang‐Shen Lin, Lu-Chia Tseng, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 140-140
Open Access | Times Cited: 8
An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma
Akinsola Oyelakin, Jennifer Sosa, Kasturi Bala Nayak, et al.
NAR Cancer (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 3
Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma
Keiji Tasaka, Hiroo Ueno, Kai Yamasaki, et al.
Cancer Science (2021) Vol. 113, Iss. 4, pp. 1535-1541
Open Access | Times Cited: 6
An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB(+) Solid Tumor Neoplastic Cells
Sofia K. Georgiou‐Siafis, Αndroulla N. Miliotou, Charikleia Ntenti, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2885-2885
Open Access | Times Cited: 4
Adaptive immunity is required for durable responses to alectinib in murine models of EML4-ALK lung cancer
Emily K. Kleczko, Trista K. Hinz, Teresa T. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Clinical and prognostic significance analysis of glycolysis‐related genes in HNSCC
Qiuyun Yuan, Mengqian Mao, Xiaoqiang Xia, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 2
Closed Access
A Systemic and Integrated Analysis of p63-Driven Regulatory Networks in Mouse Oral Squamous Cell Carcinoma
Alexandra Glathar, Akinsola Oyelakin, Kasturi Bala Nayak, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 446-446
Open Access | Times Cited: 1
Recent Advances in Eyelid Tumors
Deepsekhar Das, Bhavna Chawla
Advances in Ophthalmology and Optometry (2024) Vol. 9, Iss. 1, pp. 111-119
Closed Access
Evaluation of KRASG12C Inhibitor Responses in Novel Murine KRASG12C Lung Cancer Cell Line Models
Daniel J Sisler, Trista K. Hinz, Anh T. Le, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Plasma Cell-Free circRNAs Panel Act as Fingerprint Predicts the Occurrence of Laryngeal Squamous Cell Carcinoma
Jiahui Han, Qiuhong Lin, Chunguang Dong
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Data from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
Ritu Chaudhary, Robbert J.C. Slebos, Leenil C. Noel, et al.
(2023)
Open Access
Adaptive immunity is required for durable responses to alectinib in murine models of EML4-ALK lung cancer
Raphael A. Nemenoff, Emily K. Kleczko, Trista K. Hinz, et al.
Research Square (Research Square) (2022)
Open Access
Novel EGFR-Mutant Mouse Models of Lung Adenocarcinoma Reveal Adaptive Immunity Requirement for Durable Osimertinib Response
Emily K. Kleczko, Anh T. Le, Trista K. Hinz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Plasma Cell-free circRNAs Panel Act as Fingerprint Predicts the Occurrence of Laryngeal Squamous Cell Carcinoma
Jiahui Han, Qiuhong Lin, Chunguang Dong
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top